HIV SeropositivityHIV SeroprevalenceHIV InfectionsSubstance Abuse, IntravenousSexual BehaviorRisk FactorsDisease ProgressionSeroepidemiologic StudiesAntibodies, ViralAcquired Immunodeficiency SyndromeAntibodies, BacterialChlamydophila pneumoniaeImmunoglobulin GChlamydophila InfectionsEnzyme-Linked Immunosorbent AssaySerologic TestsHIV SeronegativityPrevalenceHelicobacter pyloriHelicobacter InfectionsHIV-1ToxocariasisCytomegalovirus InfectionsAntibodies, ProtozoanAIDS SerodiagnosisCross-Sectional StudiesCase-Control StudiesToxoplasmosisHepatitis CHerpesvirus 2, HumanCohort StudiesToxocaraCD4 Lymphocyte CountBlood DonorsProspective StudiesPapillomavirus InfectionsHomosexualityTime FactorsAge FactorsRural PopulationNeosporaAIDS-Related Opportunistic InfectionsCytomegalovirusBrazilAnti-HIV AgentsSyphilisHerpes GenitalisImmunoglobulin AToxoplasmaHuman papillomavirus 16Viral LoadCell CycleOdds RatioFollow-Up StudiesImmunoglobulin MRisk-TakingHIV AntigensSexual PartnersHomosexuality, Male